New drug duo shows promise against stubborn whipworm in kids
NCT ID NCT06188715
First seen Sep 30, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study tested whether combining two drugs (moxidectin and albendazole) works better than the standard single drug for treating whipworm infections in children aged 6-12. The trial involved 224 children in Tanzania and measured how many were cured and how much the infection reduced. The goal is to find a more effective treatment for this common intestinal parasite.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICHURIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Public Health Laboratory Ivo de Carneri
Chake Chake, Tanzania
Conditions
Explore the condition pages connected to this study.